In the lead discovery phase, researchers systematically screen large compound libraries to identify promising candidates. This rigorous process involves testing thousands of molecules to isolate those that exhibit the desired pharmacological properties. Emphasizing quality and reproducibility, this phase lays the groundwork for further development, ensuring that selected compounds reliably produce the intended effects.
Find biochemical product offerings for the lead discovery workflow stage:
- Amino acids for compound library screening and hit identification
- Biological buffers for drug discovery workflows
- Chelating and reducing agents for assay development
- Detergents for protein solubilization and screening assays
- Glycoconjugates for target interaction studies
- High-purity biochemicals for reproducible drug discovery research
- Metabolism assay kits for enzyme activity analysis
- Metabolite libraries for lead discovery and pathway analysis
Biological buffers for drug discovery workflows
Maintaining optimal pH and ionic strength for enzymatic reactions, ligand binding, and assays, biological buffers ensure accurate and reproducible results when screening potential drug candidates. Choose from BioPerformance Certified buffers designed for consistent, reproducible results.
Chelating and reducing agents for assay development
By keeping proteins in a reduced, active state, chelating and reducing agents ensure proper functionality during assays and facilitate accurate screening of potential therapeutics. Select from a broad range of chelating and reducing agents for biochemistry and proteomics.
Detergents for protein solubilization and screening assays
Detergents solubilize membrane proteins while maintaining their native conformation, ensuring proper functionality and stability for therapeutic applications. Explore our portfolio of biological detergents, including REACH-compliant biodegradable options.
Metabolite libraries for lead discovery and pathway analysis
Metabolite libraries support the identification of bioactive molecules and deepen the understanding of metabolic pathways, which is essential for optimizing lead candidates during the discovery process. Access ready-to-use solutions, plated libraries, and pathway-specific kits for streamlined metabolite screening.
Related categories
We offer a comprehensive range of high-purity amino acids and derivatives important to metabolomic pathways and protein structure for your research needs.
Our portfolio of high-purity biological buffers in various formulation and packaging formats provide superior solution stability and pH control.
Choose from our wide range of reducing agents and chelating agents for all your research needs in biochemistry and proteomics.
Surfactants across all charge types, including REACH-compliant biodegradable alternatives.
Proteoglycans, glycoproteins, and glycolipids – a comprehensive selection for every application.
BioUltra, BioXtra and BioPerformance — certified grades for contamination-sensitive workflows.
We offer a broad range of metabolism assay kits for the convenient and dependable analysis of metabolites and enzymes for all your research.
Primary pathway compounds in ready-to-use formats for metabolomics profiling and identification.
Related resources
- Article: Exploring the Future of Drug Discovery with DNA Encoded Libraries (DELs)
DNA encoded libraries offer a paradigm shift in drug discovery by leveraging the power of molecular biology and high-throughput screening.
- Fast-Tracking Drug Discovery with an AI Boost
AIDDISONTM is a powerful software platform meant to shrink this painstaking step in the drug development process.
Explore Our Products and Services
Aldrich Market Select offers online ordering of small molecule libraries and chemistry building blocks for compound management.
AIDDISON™ software supports drug discovery through molecular design, pharmacophore searches, and molecular docking for effective screening.
Discover optimal synthetic routes faster with SYNTHIA® retrosynthesis software, expert-coded to discover efficient pathways from millions of starting materials.










